Literature DB >> 230981

Inhibition by digoxin and SC4453 of (Na+ + K+)-ATPase prepared from human heart, guinea-pig heart and guinea-pig brain.

T Godfraind, D N Tona Lutete.   

Abstract

SC4453 is a digoxin analogue with a pyridazine instead of a lactone ring on C17 beta. SC4453 was compared with digoxin with respect to inhibition of (Na+ + K+)-ATPase prepared from human heart, guinea-pig heart and guinea-pig brain. SC4453 was slightly less potent than digoxin but showed a similar sensitivity to K+. As for cardenolides, species differences in sensitivity to SC4453 were accounted for by differences in the rate of dissociation from the receptors. These observations confirm that the human heart is one of the tissues most sensitive to cardiac glycosides.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 230981     DOI: 10.1016/0014-2999(79)90237-1

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  6 in total

1.  Distribution of SC-4453, a new semi-synthetic derivative of digoxin, following an infusion preceded by an i.v. loading dose in the guinea-pig. Binding to plasma proteins.

Authors:  F Randimbivololona
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1988 Jan-Mar       Impact factor: 2.441

2.  Influence of 16 beta formylation on Na, K-ATPase inhibition by cardiac glycosides.

Authors:  A De Pover; T Godfraind
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-11       Impact factor: 3.000

3.  Low-dose ouabain constricts small arteries from ouabain-hypertensive rats: implications for sustained elevation of vascular resistance.

Authors:  Jin Zhang; John M Hamlyn; Eiji Karashima; Hema Raina; Joseph R H Mauban; Michelle Izuka; Roberto Berra-Romani; Alessandra Zulian; W Gil Wier; Mordecai P Blaustein
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-07-17       Impact factor: 4.733

4.  Reduced cAMP levels and glycogen phosphorylase activation in isoproterenol perfused SHR myocardium.

Authors:  R V Sharma; R C Gupta; M Ramanadham; R C Venema; R C Bhalla
Journal:  Basic Res Cardiol       Date:  1983 Nov-Dec       Impact factor: 17.165

5.  The lead structure in cardiac glycosides is 5 beta, 14 beta-androstane-3 beta 14-diol.

Authors:  W Schönfeld; J Weiland; C Lindig; M Masnyk; M M Kabat; A Kurek; J Wicha; K R Repke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-06       Impact factor: 3.000

6.  Possible mechanism of digoxin-induced convulsions.

Authors:  S K Kulkarni; A K Mehta
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.